AL

Anugu Laxmi Narasimha Reddy

Active Director Director DIN 07415910
DIN 07415910 First appointment May 2016 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Anugu Laxmi Narasimha Reddy

Data last updated:

Anugu Laxmi Narasimha Reddy is a Director at Suraksh Pharmaceuticals Private Limited (since 2016). The company operates in Healthcare.

DIN 07415910
Primary Designation Director
Industry Healthcare
First Appointment 10 May 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 May 20162016Active

Board colleagues of Anugu Laxmi Narasimha Reddy

NameDINCompanyDesignation
Anugu Vani07416063Suraksh Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Suraksh Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anugu Laxmi Narasimha Reddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anugu Laxmi Narasimha Reddy

Anugu Laxmi Narasimha Reddy currently holds 1 directorship: Suraksh Pharmaceuticals Private Limited (Director, since 10 May 2016).

Anugu Laxmi Narasimha Reddy was first appointed on 10 May 2016 as Director at Suraksh Pharmaceuticals Private Limited.

The current boards of Anugu Laxmi Narasimha Reddy's companies include Anugu Vani (Suraksh Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available